OEM News

Medimaps, Radiobotics Begin Merger to Grow AI-Driven Musculoskeletal Imaging

The combined company will offer a suite of AI-enabled medical imaging solutions in X-ray and DXA modalities.

Author Image

By: Sam Brusco

Associate Editor

Medimaps Group and Radiobotics revealed they have begun a strategic merger agreement.

The merger will combine the two specialized artificial intelligence (AI) medical imaging analysis companies to speed adoption of AI-enabled musculoskeletal imaging. The combined company will offer a suite of AI-enabled medical imaging solutions in X-ray and DXA modalities, ranging from automated fracture detection and opportunistic bone fragility assessment to fracture risk prediction.

Medimaps’ bone microarchitecture solutions like TBS Osteo and TBS Reveal together with Radiobotics’ flagship solution for detecting trauma-related findings will integrate into existing radiology workflows through PACS-enabled capabilities.

The combined organization’s mission will be to solve the “silent crisis” of bone health by closing the gap between reactive diagnostics and preventative care. It will created the first end-to-end MSK AI ecosystem, where each X-ray becomes a tool for both detection and long-term risk prediction.

“This merger represents a pivotal milestone in Medimaps Group’s long-term strategy to strengthen our leadership in bone health assessment,” said Univ.-Prof. Dr. Didier Hans, Co-founder and CEO of Medimaps Group. “Our ambition is to give radiologists a single, trusted platform that brings together fracture detection and fracture risk prediction across the continuum of care, so clinicians can make better decisions, patients receive better outcomes, and healthcare systems benefit from more efficient, evidence-based care.”

A combined executive team will lead the new company to ensure continuity in strategy and support while preserving both brands’ MSK expertise.

“Radiobotics has always been driven by scientific rigor and real-world clinical impact,” says Peter Ulvskjold, CEO of Radiobotics and member of the Medimaps Group executive committee. “Joining Medimaps Group will accelerate access to our technology. It’s an important step in our vision to ensure patients receive immediate and precise, expert-level care in MSK imaging, 24/7, regardless of time, infrastructure, or staffing constraints.”

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters

Topics